Related Experiment Video
Updated: Jun 2, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
High fat diet induced diabetic cardiomyopathy
Ellen Dirkx1, Robert W Schwenk, Jan F C Glatz
1Department of Molecular Genetics, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands. ellen.dirkx@gen.unimaas.nl
High levels of fatty acids (FAs) force the heart to use FAs instead of glucose, leading to insulin resistance and diabetic cardiomyopathy. This metabolic shift damages heart function and structure.
Area of Science:
- Cardiovascular Biology
- Metabolic Diseases
- Molecular Cardiology
Background:
- Chronic high plasma long-chain fatty acids (FAs) alter cardiac substrate utilization, favoring FA uptake over glucose.
- This metabolic shift is associated with increased FA transporter CD36 expression and leads to cardiac insulin resistance and diabetic cardiomyopathy.
Purpose of the Study:
- To review the lipid-induced changes linking metabolic perturbations in type 2 diabetes with cardiac remodeling and dysfunction.
- To elucidate the role of fatty acids, peroxisome proliferator-activated receptors (PPARs), and reactive oxygen species (ROS) in the development of diabetic cardiomyopathy.
Main Methods:
- Literature review focusing on the molecular and cellular mechanisms of lipid-induced cardiac dysfunction.
- Analysis of signaling pathways affected by lipid intermediates like diacylglycerols (DAG) and ceramide.
Main Results:
- Increased FA uptake and utilization by the heart, driven by CD36 and PPARs, leads to lipid overload.
- Lipid overload increases reactive oxygen species (ROS) production and accumulation of diacylglycerols (DAG) and ceramide, impairing insulin signaling.
- Metabolic changes result in structural alterations affecting cardiac contractile function.
Conclusions:
- Metabolic perturbations characteristic of type 2 diabetes, particularly lipid accumulation, are key drivers of cardiac remodeling and dysfunction.
- Understanding these lipid-induced pathways is crucial for developing therapeutic strategies against diabetic cardiomyopathy.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Type II Diabetes II: Pathophysiology
Diabetic Nephropathy
Heart Failure II: Pathophysiology

